Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicus PharmaFRA:N460 13 Market Cap is €18.49 Mil as of Jul. 14, 2026. GuruFocus rates FRA:N460 with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Medicus Pharma ranks worse than 78.42% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medicus Pharma's share price for the quarter that ended in Mar. 2026 was €2.46. Medicus Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 40.00 Mil. Therefore, Medicus Pharma's market cap for the quarter that ended in Mar. 2026 was €98.39 Mil.
Medicus Pharma's quarterly market cap
increased
from Sep. 2025 (€51.59 Mil) to Dec. 2025 (€61.93 Mil) and
increased
from Dec. 2025 (€61.93 Mil) to Mar. 2026 (€98.39 Mil).
Medicus Pharma's annual market cap
increased
from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€28.12 Mil) and
increased
from Dec. 2024 (€28.12 Mil) to Dec. 2025 (€61.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medicus Pharma's Enterprise Value for Today is €15.22 Mil.
Medicus Pharma (FRA:N460) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medicus Pharma Market Cap Related Terms
Medicus Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Medicus Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:N460 vs NSRX, MIRA, SCLX: Market Cap Comparison
For the Drug Manufacturers - General subindustry, Medicus Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicus Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Medicus Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medicus Pharma's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Pharma (FRA:N460) has a Market Cap of €18.49 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medicus Pharma and its competitors. According to the industry distribution chart, Medicus Pharma ranks #803 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 78.4%.
Is Medicus Pharma's Market Cap too high?
Medicus Pharma's current Market Cap is €18.49 Mil. Based on the distribution chart, Medicus Pharma ranks #803 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Market Cap compare to NSRX and MIRA?
According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #803 out of 1024 companies for Market Cap. This places Medicus Pharma in the lower half of its industry. The industry median Market Cap is 211.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 211.96, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medicus Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 211.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Pharma's current Market Cap is €18.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (FRA:N460) has a current Market Cap of €18.49 Mil. The current Market Cap is €18.49 Mil. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medicus Pharma (FRA:N460), the current Market Cap is €18.49 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
13GF Score
Get the complete analysis for FRA:N460
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N460 has been successfully added to your 
